Curaleaf Holdings, Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Boris Alexis Jordan
- Full Time Employees
- 5,554
- Sector
- Process industries
- Industry
- Agricultural commodities/Milling
- Address
- 290 Harbor Drive Stamford CT United States 06902
- IPO Date
- Apr 7, 2021
- Website
- curaleaf.com
- Similar Companies
- Business
- Curaleaf Holdings, Inc. (Ticker: CURA.TO) operates as a leading international cannabis company focused on the cultivation, processing, and retail sale of cannabis products. The company offers a diverse portfolio of branded consumer products including flower, pre-rolls, and concentrates under its flagship Select brand; vaporizer cartridges under the Select Elite and Select Essentials lines; edibles such as gummies, chocolates, and beverages under Grassroots and Curaleaf brands; and tinctures, topicals, and other wellness products; alongside wholesale services to third-party dispensaries and cultivation operations supporting medical and adult-use markets. Curaleaf serves medical patients and recreational consumers primarily in the United States through its network of Curaleaf retail dispensaries and Quickleaf delivery services, with additional operations in Europe via subsidiaries like PRIMA Cannabis and Emmac Life Sciences. Founded in 2010 and headquartered in Stamford, Connecticut, the company maintains a vertically integrated model across 23 U.S. states and select international markets. In recent developments within the last two years, Curaleaf expanded its European footprint through the 2024 acquisition of a majority stake in UK-based PRIMA Cannabis, strengthening its medical cannabis distribution; launched new product lines including low-dose edibles and beverage formats in key U.S. markets amid regulatory approvals; formed strategic partnerships with pharmaceutical distributors for international expansion; and benefited from uplisted trading capabilities on major exchanges following favorable U.S. federal rescheduling progress in 2024-2025.
Company News
Aurora Rejects Curaleaf's Higher Bid, But the Takeover Fight Isn't Over
Curaleaf Continues Florida Expansion with Port Orange Dispensary Opening
Curaleaf Challenges Aurora's Unilateral Rejection of Its Enhanced Proposal
Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Here’s What Happened
Curaleaf Relocates Gettysburg Dispensary to York, Bringing Care Closer to Patients in South Central Pennsylvania
Aurora Cannabis Reaffirms Recommendation to Shareholders: REJECT Curaleaf's Revised Hostile Bid; Preserve Opportunities for Future Upside
Curaleaf Continues Florida Expansion with Wellington Dispensary Opening
The Deep Value Play for Growth Investors Isn't Artificial Intelligence, It's This Forgotten Industry
Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here's Why I Think It Can Go Even Higher
Head to Head Survey: Curaleaf (OTCMKTS:CURLF) versus LogicMark (OTCMKTS:LGMKD)
Aurora Urges Shareholders to Take No Action to Revised Hostile Bid by Curaleaf as Formal Review Underway
Curaleaf Files Update to Offering Circular
Curaleaf's Higher Aurora Bid Raises the Stakes in Cannabis Consolidation
Curaleaf Files Update to Offering Circular
Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid
Curaleaf raises Aurora Cannabis offer by 25%
Curaleaf Enhances Offer to Acquire Aurora Cannabis
Curaleaf (OTCMKTS:CURLF) Shares Gap Down – What’s Next?
Curaleaf Marks Seven Years and $600,000 Donated For Breast Cancer Action Month
Curaleaf to Report Third Quarter 2026 Financial and Operational Results